Research Article

Evaluation of HLA-G 14 bp Ins/Del and +3142G>C Polymorphism with Susceptibility and Early Disease Activity in Rheumatoid Arthritis

Table 4

Baseline demographic and clinical characteristics of total follow-up cohort and the remitting and nonremitting subgroups.

ParametersTotal patients ()Remitting patients ()Nonremitting patients ()

Age (mean ± SD)45.56 ± 16.9946.26 ± 17.2244.86 ± 17.34NS

Gender (%)
 Male 2 (6.7)2 (13.3)0 (0.0)NS
 Female28 (93.3)13 (86.6)15 (100.0)

BMI (Kg/m)   (mean ± SD)25.18 ± 5.2424.87 ± 3.3425.52 ± 6.84NS

Cigarette (pack/years; mean ± SD)0.33 ± 1.820.00 ± 0.000.66 ± 2.58

Hookah (%)4 (13.3)1 (6.6)3 (20)NS

EducationNS
 Illiterate (%)12 (40.0)6 (40.0)6 (40.0)
 Less than diploma (%)5 (16.7)1 (6.6)4 (26.7)
 Diploma (%)8 (26.6)4 (26.7)4 (26.7)
 Higher education (%)5 (16.7)4 (26.7)1 (6.6)

Length of symptom prior to study (months; mean ± SD)8.20 ± 4.228.20 ± 4.638.20 ± 3.94NS

Positive rheumatoid factor (%)26 (86.7)12 (80)14 (93.3)NS

ComorbidityNS
 No comorbidity (%)17 (56.6)7 (80.0)10 (66.6)
 Type 2 diabetes mellitus (%)3 (10.0)1 (6.6)2 (13.3)
 Hypertension (%)6 (20.0)5 (33.3)1 (6.6)
 Dyslipidemia (%)6 (20)2 (13.3)4 (26.6)
 Other factors (%)5 (16.6)4 (26.6)1 (6.6)

Nonsignificant.